Tribunal dismissing a raft of appeals including those filed by SREI entities
The country's plant-based meat market is estimated at $30-40 mn
Net profit up 18.6% on 10.3% rise in revenue; says near-term outlook uncertain as growth moderating, inflation high
Flight to New York departs Thursday morning, those to Chicago and San Francisco from Delhi in the afternoon
India is already one of the top sourcing markets for Walmart and the retail major has set an ambitious goal of exporting USD 10 billion from India each year by 2027
The company had posted a consolidated net profit of Rs 350.14 crore in the October-December quarter a year ago
Despite the ongoing pandemic-related volatility and pressure associated with tight global labour markets, WNS continues to perform well and deliver solid financial results, a company official said
Jio Platforms is the parent of telecom player Reliance Jio
The company will utilize Rs 947 crore from the proceeds of the issue to repay/prepay debt which as of March 2021 stood at Rs 1,252.6 crore
A survey has revealed that 77 per cent of respondents believe these new-age firms have a positive role in boosting the employment scenario in the country.
The company has started accepting bookings for the second batch after the first lot was completely sold out
Urban Company partners earned an average of Rs 297 per hour, net of commissions, fee and all associated product and travel costs.
Stock tanks 18.3% as independent directors resign
This, after the insolvency appellate tribunal rejected the approval of Rs 2,692 crore bid by Vedanta Chairman Anil Agarwal-promoted Twin Star Technologies earlier this month
By Nidhi Verma and Gavin Maguire
Telangana is one of the few states that came out with a data centre policy in India, way back in 2016
The fund will be made up of its own resources and outside investment, Agarwal said, adding that it may also finance the BPCL acquisition through debt
Business Standard brings you the top headlines on Thursday
The market capitalisation of the token currently is $31 million.
Natco Pharma Ltd said it has signed a non-exclusive license agreement with the Medicines Patent Pool (MPP), Switzerland to manufacture and sell Molnupiravir capsules 200 mg for treatment of COVID-19.